Communities Fighting COVID Return to School
NCT05150860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 852
Last updated 2025-01-17
Summary
San Diego State University (SDSU), a designated Hispanic-serving institution, is partnering with Sweetwater Union High School District, an independent public school district serving 90% ethnic minority and a high proportion of socioeconomically disadvantaged students, and other community partners, to generate evidence for effective and feasible COVID-19 testing for unvaccinated and medically vulnerable middle school students and staff as part of broader COVID mitigation strategies including vaccination to return students back to school safely.
Conditions
Interventions
- BEHAVIORAL
-
At-home COVID-19 testing
At-home over-the-counter (OTC) COVID-19 testing kits provided to middle school students and staff
- BEHAVIORAL
-
Onsite COVID-19 testing
Onsite COVID-19 testing for middle school students and staff
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
San Diego State University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-17
- Primary Completion
- 2022-04-02
- Completion
- 2022-04-02
Countries
- United States
Study Locations
More Related Trials
-
The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions
NCT05055505 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Performance of Rapid Diagnostics for SARS-CoV-2 Self-testing in the Hands of Untrained
NCT05605769 ·Status: COMPLETED
-
Screening for COVID-19
NCT04615208 ·Status: WITHDRAWN
-
Study of the Effectiveness of The COVID-19 Vaccine
NCT05766176 ·Status: COMPLETED
-
Protecting Our Community: COVID-19 Testing
NCT04866303 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
NCT06055218 ·Status: COMPLETED
-
Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children
NCT05613751 ·Status: RECRUITING ·Phase: NA
-
Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere
NCT06928129 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Retrospective Study of COVID-19 Treatments
NCT04949230 ·Status: COMPLETED
-
Reduction of COVID 19 Transmission to Health Care Professionals
NCT04462627 ·Status: COMPLETED ·Phase: NA
-
Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF
NCT01303068 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
NCT06902194 ·Status: RECRUITING
-
COVID-19 Effectiveness Study in the Philippines
NCT05518760 ·Status: UNKNOWN
-
Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.
NCT06259110 ·Status: NOT_YET_RECRUITING
-
Assessing Performance of the Testing Done Simple Covid 19 Antigen Test
NCT05610449 ·Status: COMPLETED
-
Predictors of COVID-19 Infection and Disease Progression
NCT04484597 ·Status: UNKNOWN
-
Prospective COVID-19 Cohort Study, Dominican Republic
NCT04898738 ·Status: COMPLETED ·Phase: NA
-
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
NCT05621993 ·Status: UNKNOWN
-
Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis
NCT00633191 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Rapid Screening Circuit of COVID 19 in Schools, Pilot Study
NCT04878809 ·Status: COMPLETED ·Phase: NA
-
Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children
NCT04838834 ·Status: COMPLETED
-
FebriDx® Pediatric Validation Study
NCT07211997 ·Status: RECRUITING
-
Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department
NCT02957136 ·Status: COMPLETED ·Phase: NA
-
Virus Interactions in the Respiratory Tract; a Cohort Study With Children
NCT05318235 ·Status: COMPLETED
-
Passive Immunotherapy In Patients With SARS CoV-2
NCT05578391 ·Status: COMPLETED ·Phase: PHASE2